⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1763447 | 1.00 | — | — | |
| SCHEMBL1685077 | 0.89 | — | — | |
| SCHEMBL361643 | 0.89 | — | — | |
| SCHEMBL3657197 | 0.84 | — | — | |
| SCHEMBL3657198 | 0.84 | — | — | |
| SCHEMBL16548528 | 0.83 | — | — | |
| SCHEMBL18924435 | 0.83 | — | — | |
| SCHEMBL2464884 | 0.80 | — | — | |
| SCHEMBL105368 | 0.80 | — | — | |
| SCHEMBL333324 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250343048-A1 | ETCHING METHOD | RESONAC CORPORATION (JP) | 2025-11-06 | — | — | US | disclosed |
| EP-4481794-A1 | ETCHING METHOD | Resonac Corporation (JP) | 2024-12-25 | — | — | EP | disclosed |
| CN-112823148-B | Process for producing perfluoroalkyne compound | 大金工业株式会社 | 2024-10-15 | — | — | CN | disclosed |
| CN-118679554-A | Etching method | 株式会社力森诺科 | 2024-09-20 | — | — | CN | disclosed |
| CN-112912360-B | Process for producing perfluorocycloolefin compound | 大金工业株式会社 | 2024-05-07 | — | — | CN | disclosed |
| CN-117924019-A | Process for producing perfluoroalkyne compound | 大金工业株式会社 | 2024-04-26 | — | — | CN | disclosed |
| WO-2023157441-A1 | ETCHING METHOD | 株式会社レゾナック | 2023-08-24 | — | — | WO | disclosed |
| CN-102282113-B | Process for producing fluoroolefin compound | 阿克马法国公司 | 2016-07-06 | — | — | CN | disclosed |
| US-8547011-B2 | Layered product, luminescence device and use thereof | ZEON CORPORATION (JP) | 2013-10-01 | — | — | US | disclosed |
| EP-1745922-B1 | MULTILAYER BODY, LIGHT-EMITTING DEVICE AND USE THEREOF | ZEON CORP (JP) | 2012-08-29 | — | — | EP | disclosed |
| US-5639473-A | SUBJECTING AQUEOUS MEDIUM CONTAINING BIOCOMPATIBLE MATERIAL CAPABLE OF BEING CROSSLINKED BY DISULFIDE BONDS AND NUCLEIC ACID CONSTRUCT TO HIGH INTENSITY ULTRASOUND WAVES | VIVORX PHARMACEUTICALS, INC. (US) | 1997-06-17 | — | — | US | disclosed |
| US-5635207-A | SUBJECTING AQUEOUS MEDIUM CONTAINING OXYGEN BINDING PROTEIN TO HIGH INTENSITY ULTRASOUND CONDITIONS TO PROMOTE CROSSLINKING AND FORM POLYMERIC SHELL OF SPECIFIED SIZE | VIVORX PHARMACEUTICALS, INC. (US) | 1997-06-03 | — | — | US | disclosed |
| US-5512268-A | CONTRAST AGENTS ENCAPSULATED IN BIOCOMPATIBLE POLYMER SHELL CROSSLINKED WITH DISULFIDE LIKAGE | VIVORX PHARMACEUTICALS, INC. (US) | 1996-04-30 | — | — | US | disclosed |
| US-5508021-A | BIOCOMPATIBLE CROSSLINKED POLYMER CONTAINING IMAGING AGENT | VIVORX PHARMACEUTICALS, INC. (US) | 1996-04-16 | — | — | US | disclosed |
| US-5505932-A | CONTAINING CONTRAST AGENT | VIVORX PHARMACEUTICALS, INC. (US) | 1996-04-09 | — | — | US | disclosed |
| US-5498421-A | IN A POLYMERIC SHELL CONTAINING SULFHYDRYL AND/OR DISULFIDE GROUPS | VIVORX PHARMACEUTICALS, INC. (US) | 1996-03-12 | — | — | US | disclosed |
| CN-1118136-A | Method for in vivo delivery of biologicals and compositions for use in the method | CLOVER CONS LTD (CH) | 1996-03-06 | — | — | CN | disclosed |
| EP-0693924-A1 | METHODS FOR $i(IN VIVO) DELIVERY OF BIOLOGICS AND COMPOSITIONS USEFUL THEREFOR | VIVORX PHARMACEUTICALS, INC. (US) | 1996-01-31 | — | — | EP | disclosed |
| US-5362478-A | Shell comprising biocompatible naturally occurring polymer which is crosslinked by disulfide bonds and which, before crosslinking, has covalently attached sulfhydryl or disulfide groups | VIVORX PHARMACEUTICALS, INC. (US) | 1994-11-08 | — | — | US | disclosed |
| WO-1994018954-A1 | METHODS FOR IN VIVO DELIVERY OF BIOLOGICS AND COMPOSITIONS USEFUL THEREFOR | VIVORX PHARMACEUTICALS, INC. (US) | 1994-09-01 | — | — | WO | disclosed |